Plasma 25-hydroxyvitamin D concentration and lymphoma risk: results of the European Prospective Investigation into Cancer and Nutrition.

BACKGROUND The relation between vitamin D status and lymphoma risk is inconclusive. OBJECTIVE We examined the association between prediagnostic plasma 25-hydroxyvitamin D [25(OH)D] and lymphoid cancer risk. DESIGN We conducted a study nested within the European Prospective Investigation into Cancer and Nutrition cohort of 1127 lymphoma cases and 1127 matched controls with a mean follow-up time of 7.1 y. Conditional logistic regression was used to estimate multivariable-adjusted incidence rate ratios of lymphoma risk in relation to plasma 25(OH)D. Season-standardized and season-specific 25(OH)D quartiles were used. We also analyzed 25(OH)D as a continuous variable and used predefined cutoffs. RESULTS No statistically significant association between plasma 25(OH)D and overall lymphoid cancer risk was observed. A positive association for B-cell non-Hodgkin lymphoma was noted only in those with a diagnosis made during the first 2 y of follow-up (P-heterogeneity = 0.03), which suggests the possibility of reverse causality. Further analysis restricted to participants with ≥2 y of follow-up time showed a significant association between 25(OH)D and chronic lymphocytic leukemia (CLL) (n = 161): adjusted incidence rate ratios were 0.40 (95% CI: 0.18, 0.90; P-trend = 0.05) and 0.31 (95% CI: 0.13, 0.76; P-trend = 0.03) for the top compared with the bottom season-standardized and season-specific quartiles, respectively. Data on dietary vitamin D intake provided further support for the observed association (incidence rate ratio: 0.33; 95% CI = 0.12, 0.89; P-trend = 0.006). CONCLUSIONS Our findings do not support a protective role of high 25(OH)D concentration in lymphoid cancers overall. However, they suggest that higher concentrations of 25(OH)D are associated with a reduced risk of CLL.

[1]  C. Camargo,et al.  Randomized Trial of Vitamin D Supplementation and Risk of Acute Respiratory Infection in Mongolia , 2012, Pediatrics.

[2]  P. Bracci,et al.  Intake of Vitamins D and A and Calcium and Risk of Non-Hodgkin Lymphoma: San Francisco Bay Area Population-Based Case-Control Study , 2012, Nutrition and cancer.

[3]  W. Grant,et al.  Antimicrobial implications of vitamin D , 2011, Dermato-endocrinology.

[4]  L. Bernstein,et al.  Adulthood residential ultraviolet radiation, sun sensitivity, dietary vitamin D, and risk of lymphoid malignancies in the California Teachers Study. , 2011, Blood.

[5]  P. Lips,et al.  Worldwide vitamin D status. , 2011, Best practice & research. Clinical endocrinology & metabolism.

[6]  E. Hyppönen,et al.  Vitamin D status has a linear association with seasonal infections and lung function in British adults , 2011, British Journal of Nutrition.

[7]  Elias Campo,et al.  The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications. , 2011, Blood.

[8]  JoAnn E. Manson,et al.  The 2011 Report on Dietary Reference Intakes for Calcium and Vitamin D from the Institute of Medicine: What Clinicians Need to Know , 2010, The Journal of clinical endocrinology and metabolism.

[9]  J. Cerhan,et al.  Vitamin D insufficiency and prognosis in chronic lymphocytic leukemia. , 2011, Blood.

[10]  J. Souberbielle,et al.  Cross-reactivity of 25-hydroxy vitamin D2 from different commercial immunoassays for 25-hydroxy vitamin D: an evaluation without spiked samples , 2011, Clinical chemistry and laboratory medicine.

[11]  C. Mathers,et al.  Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 , 2010, International journal of cancer.

[12]  Gavin Giovannoni,et al.  A ChIP-seq defined genome-wide map of vitamin D receptor binding: associations with disease and evolution. , 2010, Genome research.

[13]  D. Bruce,et al.  Vitamin D and host resistance to infection? Putting the cart in front of the horse , 2010, Experimental biology and medicine.

[14]  M. Calvo,et al.  Correcting poor vitamin D status: do older adults need higher repletion doses of vitamin D3 than younger adults? , 2010, Molecular nutrition & food research.

[15]  W. Willett,et al.  American Journal of Epidemiology Original Contribution Circulating 25-hydroxyvitamin D and Risk of Non-hodgkin Lymphoma Cohort Consortium Vitamin D Pooling Project of Rarer Cancers , 2022 .

[16]  R. Hayes,et al.  Circulating 25-Hydroxyvitamin D and the Risk of Rarer Cancers: Design and Methods of the Cohort Consortium Vitamin D Pooling Project of Rarer Cancers , 2010, American journal of epidemiology.

[17]  H. Adami,et al.  Pigmentary Characteristics, UV Radiation Exposure, and Risk of Non–Hodgkin Lymphoma: a Prospective Study among Scandinavian Women , 2010, Cancer Epidemiology, Biomarkers & Prevention.

[18]  R. Jorde,et al.  Tracking of serum 25-hydroxyvitamin D levels during 14 years in a population-based study and during 12 months in an intervention study. , 2010, American journal of epidemiology.

[19]  E. Engels,et al.  Common community acquired infections and subsequent risk of chronic lymphocytic leukaemia , 2009, British journal of haematology.

[20]  J. Friedberg,et al.  Vitamin D and Non-Hodgkin Lymphoma Risk in Adults: A Review , 2009, Cancer investigation.

[21]  G. Carter 25-Hydroxyvitamin D assays: the quest for accuracy. , 2009, Clinical chemistry.

[22]  C. Camargo,et al.  Association between serum 25-hydroxyvitamin D level and upper respiratory tract infection in the Third National Health and Nutrition Examination Survey. , 2009, Archives of internal medicine.

[23]  P. Hartge,et al.  A prospective investigation of serum 25‐hydroxyvitamin D and risk of lymphoid cancers , 2009, International journal of cancer.

[24]  E. Jaffe,et al.  The 2008 WHO classification of lymphomas: implications for clinical practice and translational research. , 2009, Hematology. American Society of Hematology. Education Program.

[25]  H. Hjalgrim,et al.  Infectious aetiology of Hodgkin and non‐Hodgkin lymphomas: a review of the epidemiological evidence , 2008, Journal of internal medicine.

[26]  J. Vandenbroucke,et al.  Practice of Epidemiology What Do Case-Control Studies Estimate? Survey of Methods and Assumptions in Published Case-Control Research , 2008 .

[27]  T. Hamblin,et al.  The immunodeficiency of chronic lymphocytic leukaemia. , 2008, British medical bulletin.

[28]  J. Zerwekh Blood biomarkers of vitamin D status. , 2008, The American journal of clinical nutrition.

[29]  J. Cerhan,et al.  Personal sun exposure and risk of non Hodgkin lymphoma: A pooled analysis from the Interlymph Consortium , 2008, International journal of cancer.

[30]  P. Lipsky,et al.  Modulatory Effects of 1,25-Dihydroxyvitamin D3 on Human B Cell Differentiation , 2007, The Journal of Immunology.

[31]  A. Seidler,et al.  Sun exposure and malignant lymphoma: A population‐based case–control study in Germany , 2007, International journal of cancer.

[32]  P. Lips Vitamin D status and nutrition in Europe and Asia , 2007, The Journal of Steroid Biochemistry and Molecular Biology.

[33]  N. Caporaso,et al.  Respiratory tract infections and subsequent risk of chronic lymphocytic leukemia. , 2007, Blood.

[34]  B. Armstrong,et al.  Sun Exposure and Non-Hodgkin Lymphoma , 2007, Cancer Epidemiology Biomarkers & Prevention.

[35]  J. Adams,et al.  Extra-renal 25-hydroxyvitamin D3-1α-hydroxylase in human health and disease , 2007, The Journal of Steroid Biochemistry and Molecular Biology.

[36]  J. Adams,et al.  Extra-renal 25-hydroxyvitamin D3-1alpha-hydroxylase in human health and disease. , 2007, The Journal of steroid biochemistry and molecular biology.

[37]  J. Cerhan,et al.  Ultraviolet radiation, dietary vitamin D, and risk of non-Hodgkin lymphoma (United States) , 2006, Cancer Causes & Control.

[38]  C. la Vecchia,et al.  Linoleic acid, vitamin D and other nutrient intakes in the risk of non-Hodgkin lymphoma: an Italian case-control study. , 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

[39]  H. Adami,et al.  Ultraviolet radiation exposure and risk of malignant lymphomas. , 2005, Journal of the National Cancer Institute.

[40]  J. Kaldor,et al.  Sun exposure may protect against non‐Hodgkin lymphoma: A case‐control study , 2004, International journal of cancer.

[41]  P. Lips Which circulating level of 25-hydroxyvitamin D is appropriate? , 2004, The Journal of Steroid Biochemistry and Molecular Biology.

[42]  Paul S Albert,et al.  Using lowess to remove systematic trends over time in predictor variables prior to logistic regression with quantile categories , 2003, Statistics in medicine.

[43]  C. Fegan,et al.  The vitamin D3 analog EB1089 induces apoptosis via a p53-independent mechanism involving p38 MAP kinase activation and suppression of ERK activity in B-cell chronic lymphocytic leukemia cells in vitro. , 2003, Blood.

[44]  N E Day,et al.  European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection , 2002, Public Health Nutrition.

[45]  B. Dawson-Hughes,et al.  Plasma 25-hydroxyvitamin D responses of younger and older men to three weeks of supplementation with 1800 IU/day of vitamin D. , 1999, Journal of the American College of Nutrition.

[46]  A. Staines,et al.  The increasing incidence of non-Hodgkin's lymphoma (NHL): the possible role of sunlight. , 1994, Leukemia & lymphoma.

[47]  P. Boyle,et al.  Epidemiology of non‐Hodgkin lymphoma in connecticut 1935‐1988 , 1992, Cancer.

[48]  S Greenland,et al.  On the need for the rare disease assumption in case-control studies. , 1982, American journal of epidemiology.